









Markets
/
Stocks
/
nasdaq-ufpt
/

UFP Technologies Inc

UFPT

202.470USD

-2.490-1.21%

Market hours （ET）Quotes delayed by 15 min

1.56BMarket Cap

23.27P/E TTM



UFP Technologies Inc

202.470

-2.490-1.21%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

32 / 207

Overall Ranking

128 / 4723

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Buy

Current Rating

329.500

Target Price

+62.21%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

UFP Technologies, Inc. is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other engineered custom products. Its single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, surfaces and support, wound care, wearables, orthopedic soft goods, and orthopedic implants. It is also providing engineered products and components. Typical applications of its products include military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It also engineers’ components for automotive use, such as interior trim and structural applications. These components are produced using a compression molding process. It also develops and manufactures single-use safe patient handling systems, thermoformed, heat-sealed implantable medical device components, custom-engineered foam and thermoplastic components.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 42.58% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 41.14.

Undervalued

The company’s latest PE is 23.48, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 9.02M shares, decreasing 0.01% quarter-over-quarter.

Held by Wasatch Global Investors

Star Investor Wasatch Global Investors holds 650.96K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.36.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 8.60, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 151.18M, representing a year-over-year increase of 37.21%, while its net profit experienced a year-over-year increase of 26.77%.

Score

Industry at a Glance

Previous score

8.60

Change



Financials

7.30

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.69

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.39

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.63

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 3.86, which is higher than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is 23.48, which is 44.95% below the recent high of 34.03 and -7.12% above the recent low of 25.15.

Score

Industry at a Glance

Previous score

4.69

Change

-0.83

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 32/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for UFP Technologies Inc is 329.50, with a high of 370.00 and a low of 289.00.

Score

Industry at a Glance

Previous score

7.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Buy

Current Rating

329.500

Target Price

+62.21%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

UFP Technologies Inc

UFPT

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 6.96, which is higher than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 225.42 and the support level at 189.71, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.88

Change

0.08

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.486

Neutral

RSI(14)

42.183

Neutral

STOCH(KDJ)(9,3,3)

50.825

Buy

ATR(14)

7.161

Low Volatility

CCI(14)

19.470

Neutral

Williams %R

58.382

Sell

TRIX(12,20)

-0.418

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

202.562

Sell

MA10

204.001

Sell

MA20

209.564

Sell

MA50

221.565

Sell

MA100

227.917

Sell

MA200

235.173

Sell

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 117.09%, representing a quarter-over-quarter decrease of 1.13%. The largest institutional shareholder is Wasatch Global Investors, holding a total of 650.96K shares, representing 8.44% of shares outstanding, with 12.34% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

1.01M

-2.25%

Wasatch Global Investors Inc

Star Investors

642.19K

+11.36%

The Vanguard Group, Inc.

Star Investors

520.43K

-6.36%

Neuberger Berman, LLC

345.24K

-22.06%

Congress Asset Management Company, LLP

309.39K

+9.98%

American Century Investment Management, Inc.

287.59K

+1858.25%

State Street Global Advisors (US)

283.39K

-4.36%

Boston Trust Walden Company

214.15K

+98.38%

Renaissance Technologies LLC

Star Investors

259.66K

-6.99%

Geode Capital Management, L.L.C.

180.17K

+4.17%

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 3.61, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.20. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.